secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vivos Therapeutics, Inc. (VVOS)
CIK:        0001716166
Form:       8-K
Filed at:   2025-10-24T23:59:59+00:00
Accession:  0001493152-25-019359
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vivos Therapeutics expands at-the-market equity offering under existing agreement
--------------------------------------------------------------------------------

- Filed prospectus supplement to increase aggregate offering price of common stock under ATM agreement with H.C. Wainwright & Co. (dated Feb 14, 2025).
- No specific increase amount or prior cap disclosed in the 8-K filing.
- Legal opinion on share issuance attached as Exhibit 5.1; no other material changes reported.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1716166/000149315225019359/0001493152-25-019359-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1716166/000149315225019359/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-019359

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer